Infusion Reactions in Persons Receiving the Broadly Neutralizing Antibody VRC01 or Placebo for Reduction of HIV-1 Acquisition: Results From the Phase 2b Antibody Mediated Prevention (AMP) Randomized Trials
Simbarashe Takuva(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Nyaradzo Mgodi(University of Zimbabwe), Robert De La Grecca(Infectious Disease Research Institute), Srilatha Edupuganti(Emory University), Myron S. Cohen(University of North Carolina at Chapel Hill), Stephen R. Walsh(Beth Israel Deaconess Medical Center), Carissa Karg(Infectious Disease Research Institute), Catherine Orrell(South African Medical Research Council), April K. Randhawa(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Maija Anderson(Fred Hutch Cancer Center), Javier Valencia(Asociación Civil Impacta Salud y Educación), Alice Sehurutshi(Botswana Harvard AIDS Institute Partnership), Martin R. Gaudinski(National Institute of Allergy and Infectious Diseases), Erika Rudnicki(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Lawrence Corey(Fred Hutch Cancer Center), Larissa M. Villela(Fundação Oswaldo Cruz), David N. Barnes(National Institutes of Health), Shelly Karuna(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Margarira M. Gomez Lorenzo(National Institutes of Health), John R. Mascola(National Institute of Allergy and Infectious Diseases), Kathryn Mngadi(Aurum Institute), Julie E. Ledgerwood(Vaccine Research Institute of San Diego), P. Andrew(Family Health International 360), John Hural(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Logashvari Naidoo(South African Medical Research Council), Michal Juraska(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa)
Cited by 0
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
|Science|2010|1.8k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k
Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection
|New England Journal of Medicine|1990|1.3k